A5089897569- Advanced Radiotherapy Techniques
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Atmospheric Ozone and Climate
- Management of metastatic bone disease
- Atmospheric and Environmental Gas Dynamics
- Hepatocellular Carcinoma Treatment and Prognosis
- Medical Imaging Techniques and Applications
- Atmospheric chemistry and aerosols
- Cancer Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Radiomics and Machine Learning in Medical Imaging
- MRI in cancer diagnosis
- Cancer Genomics and Diagnostics
- Colorectal and Anal Carcinomas
- Colorectal Cancer Surgical Treatments
- Renal and related cancers
- Advancements in Photolithography Techniques
- Advanced X-ray and CT Imaging
- Gastric Cancer Management and Outcomes
- Brain Metastases and Treatment
- Radiopharmaceutical Chemistry and Applications
- Radiation Therapy and Dosimetry
- Astro and Planetary Science
Sunnybrook Health Science Centre
2016-2025
Health Sciences Centre
2016-2025
University of Toronto
2015-2024
Princess Margaret Cancer Centre
2000-2024
University Health Network
2000-2024
Mount Vernon Cancer Centre
2024
Institute of Cancer Research
2024
Cambridge University Hospitals NHS Foundation Trust
2024
St Bartholomew's Hospital
2024
Wolters Kluwer (Netherlands)
2023
BackgroundLocalised prostate cancer is commonly treated with external-beam radiotherapy. Moderate hypofractionation has been shown to be non-inferior conventional fractionation. Ultra-hypofractionated stereotactic body radiotherapy would allow shorter treatment courses but could increase acute toxicity compared conventionally fractionated or moderately hypofractionated We report the findings from a randomised trial of standard-of-care versus five-fraction for low-risk intermediate-risk...
Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect biochemical clinical failure in patients localized prostate cancer unclear.
BACKGROUND Stereotactic ablative radiotherapy (SABR) is an emerging therapy for primary renal cell carcinoma. The authors assessed safety, efficacy, and survival in a multi‐institutional setting. Outcomes between single‐fraction multifraction SABR were compared. METHODS Individual patient data sets from 9 International Radiosurgery Oncology Consortium Kidney institutions across Germany, Australia, the United States, Canada, Japan pooled. Toxicities recorded using Common Terminology Criteria...
SAGE I/II ozone data from the period 1979–1991 have been used to derive global trends in both stratospheric column and as a function of altitude. A statistical model containing quasibiennial, seasonal, semiannual oscillations, linear component, first‐order autoregressive noise process was fit time series monthly zonal mean data. The trend above 17 km altitude, averaged between 65°S 65°N, is −0.30 ± 0.19%/year or −3.6% over February 1979 through April 1991. further show that nearly zero...